中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2014年
32期
5158-5165
,共8页
陈楚娴%任莉莉%蒋锦杏%张婕婕%叶丽姿%李富荣%邓春艳
陳楚嫻%任莉莉%蔣錦杏%張婕婕%葉麗姿%李富榮%鄧春豔
진초한%임리리%장금행%장첩첩%협려자%리부영%산춘염
干细胞%移植%糖尿病%骨髓%间充质干细胞%胰腺%转分化
榦細胞%移植%糖尿病%骨髓%間充質榦細胞%胰腺%轉分化
간세포%이식%당뇨병%골수%간충질간세포%이선%전분화
bone marrow%mesenchymal stem celltransplantation%diabetes mel itus%pancreas%celltransdifferentiation
背景:近年来大量研究认为骨髓间充质干细胞植入后可以改善糖尿病鼠的高血糖状态,但相关的机制尚不明确且存在一些争议。目的:探讨骨髓间充质干细胞移植到糖尿病大鼠胰腺后的作用机制。方法:将增强型绿色荧光蛋白标记的骨髓间充质干细胞移植到糖尿病大鼠胰腺包膜下,血糖仪监测血糖, RT-PCR 动态检测受体鼠胰腺组织增强型绿色荧光蛋白阳性细胞中关键转录因子的表达,免疫荧光染色观察胰腺组织中增强型绿色荧光蛋白和胰岛素共表达情况,流式细胞术分析增强型绿色荧光蛋白阳性胰腺组织细胞的细胞周期和DNA倍性。结果与结论:胰腺包膜下移植骨髓间充质干细胞能有效降低糖尿病鼠血糖;Nestin、Nkx 2.2的表达分别在移植后1,3周到达峰值,Pax 4和Ngn 3的表达在移植后4周到达峰值,胰岛素和胰高血糖素的表达至移植后12周到达峰值,PDX-1的表达在8周时达到峰值并维持至12周;免疫荧光染色发现有增强型绿色荧光蛋白和胰岛素共表达细胞;流式细胞术测定增强型绿色荧光蛋白阳性的胰腺组织细胞中处于S+G2/M期的细胞增加,细胞核型未见多倍体或非整倍体细胞。提示在胰腺微环境中,植入糖尿病鼠胰腺局部的骨髓间充质干细胞在基因调控下向胰岛β样细胞发生横向转分化,而非细胞融合获得β细胞的功能表型。
揹景:近年來大量研究認為骨髓間充質榦細胞植入後可以改善糖尿病鼠的高血糖狀態,但相關的機製尚不明確且存在一些爭議。目的:探討骨髓間充質榦細胞移植到糖尿病大鼠胰腺後的作用機製。方法:將增彊型綠色熒光蛋白標記的骨髓間充質榦細胞移植到糖尿病大鼠胰腺包膜下,血糖儀鑑測血糖, RT-PCR 動態檢測受體鼠胰腺組織增彊型綠色熒光蛋白暘性細胞中關鍵轉錄因子的錶達,免疫熒光染色觀察胰腺組織中增彊型綠色熒光蛋白和胰島素共錶達情況,流式細胞術分析增彊型綠色熒光蛋白暘性胰腺組織細胞的細胞週期和DNA倍性。結果與結論:胰腺包膜下移植骨髓間充質榦細胞能有效降低糖尿病鼠血糖;Nestin、Nkx 2.2的錶達分彆在移植後1,3週到達峰值,Pax 4和Ngn 3的錶達在移植後4週到達峰值,胰島素和胰高血糖素的錶達至移植後12週到達峰值,PDX-1的錶達在8週時達到峰值併維持至12週;免疫熒光染色髮現有增彊型綠色熒光蛋白和胰島素共錶達細胞;流式細胞術測定增彊型綠色熒光蛋白暘性的胰腺組織細胞中處于S+G2/M期的細胞增加,細胞覈型未見多倍體或非整倍體細胞。提示在胰腺微環境中,植入糖尿病鼠胰腺跼部的骨髓間充質榦細胞在基因調控下嚮胰島β樣細胞髮生橫嚮轉分化,而非細胞融閤穫得β細胞的功能錶型。
배경:근년래대량연구인위골수간충질간세포식입후가이개선당뇨병서적고혈당상태,단상관적궤제상불명학차존재일사쟁의。목적:탐토골수간충질간세포이식도당뇨병대서이선후적작용궤제。방법:장증강형록색형광단백표기적골수간충질간세포이식도당뇨병대서이선포막하,혈당의감측혈당, RT-PCR 동태검측수체서이선조직증강형록색형광단백양성세포중관건전록인자적표체,면역형광염색관찰이선조직중증강형록색형광단백화이도소공표체정황,류식세포술분석증강형록색형광단백양성이선조직세포적세포주기화DNA배성。결과여결론:이선포막하이식골수간충질간세포능유효강저당뇨병서혈당;Nestin、Nkx 2.2적표체분별재이식후1,3주도체봉치,Pax 4화Ngn 3적표체재이식후4주도체봉치,이도소화이고혈당소적표체지이식후12주도체봉치,PDX-1적표체재8주시체도봉치병유지지12주;면역형광염색발현유증강형록색형광단백화이도소공표체세포;류식세포술측정증강형록색형광단백양성적이선조직세포중처우S+G2/M기적세포증가,세포핵형미견다배체혹비정배체세포。제시재이선미배경중,식입당뇨병서이선국부적골수간충질간세포재기인조공하향이도β양세포발생횡향전분화,이비세포융합획득β세포적공능표형。
BACKGROUND:In recent years a large number of studies have suggested that bone marrow mesenchymal stem cells can ease hyperglycemia of diabetic rats, but the related mechanism is unclear and controversial. OBJECTIVE:To investigate the relevant mechanism of bone marrow mesenchymal stem cells on pancreas microenvironment in vivo in diabetic rats. METHODS:Bone marrow mesenchymal stem cells were transfected with enhanced green fluorescent protein (EGFP) and administered to diabetic rats via the subcapsular pancreas. Blood glucose levels were monitored. The expressions of the key genes in islet development in these EGFP positive pancreatic cells were analyzed by Real-time quantitative PCR at different times. EGFP and insulin double-positive cells were detected by immunofluorescence. Flow cytometry was performed to analyze cellcycle and DNA ploidy. RESULTS AND CONCLUSION:Blood glucose levels were effectively reduced after transplantation. The expressions of the key genes in islet development reached their own peak values at different times after transplantation:Nestin at week 1, Nkx 2.2 at week 3, Pax 4 and Ngn 3 at week 4, insulin and glucagon at week 12, PDX-1 at week 8 until week 12. The cells double-positive for EGFP and insulin cells were observed. In the pancreas, EGFP positive cells at S+G 2/M phase were significantly increased, and there were no polyploid and aneuploid cells. In pancreas microenvironment, the bone marrow mesenchymal stem cells transplanted into the diabetic pancreas can differentiate into isletβ-like cells under gene control, but not through the fusion with tissue cells.